Deep Dive: FDA to revoke Red No. 3 authorization
January 15th 2025, the FDA announced that they would be revoking their authorizations for Red No. 3 in food and ingested drugs. The Lycored team comments on the situation.
We love what we do, and nothing delights us more than sharing our work with the wider world.
We love what we do, and nothing delights us more than sharing our work with the wider world. In the last few weeks, we’ve appeared in the UK’s Daily Mail, The Daily Express, Healthista.com, Health & Fitness Cheat Sheet, and Women’s Running. The pieces themselves are excellent looks at wellness and vital nutrients, and we’re proud to be featured prominently. We’re also excited that Lycored friend Dr. Mark Menolascino, MD was able to assist our team in making these pieces shine. Happy reading!
January 15th 2025, the FDA announced that they would be revoking their authorizations for Red No. 3 in food and ingested drugs. The Lycored team comments on the situation.
In our latest webinar, Elizabeth Tarshish, PhD, Head of Scientific Value & Strategy at Lycored discusses Lycomato’s impact on cellular and mitochondrial health and how it promotes longevity through a...
Reflecting on my fourth year at Lycored, I'm filled with gratitude for our incredible journey together in 2024.
Interested in speaking directly with a member of our team?
Click below to get in touch.